227 related articles for article (PubMed ID: 34473231)
1. Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms.
Imgruet MK; Lutze J; An N; Hu B; Khan S; Kurkewich J; Martinez TC; Wolfgeher D; Gurbuxani SK; Kron SJ; McNerney ME
Blood; 2021 Sep; 138(9):790-805. PubMed ID: 34473231
[TBL] [Abstract][Full Text] [Related]
2. CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.
McNerney ME; Brown CD; Wang X; Bartom ET; Karmakar S; Bandlamudi C; Yu S; Ko J; Sandall BP; Stricker T; Anastasi J; Grossman RL; Cunningham JM; Le Beau MM; White KP
Blood; 2013 Feb; 121(6):975-83. PubMed ID: 23212519
[TBL] [Abstract][Full Text] [Related]
3. Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS.
An N; Khan S; Imgruet MK; Gurbuxani SK; Konecki SN; Burgess MR; McNerney ME
Blood; 2018 Jun; 131(24):2682-2697. PubMed ID: 29592892
[TBL] [Abstract][Full Text] [Related]
4. The significance of CUX1 and chromosome 7 in myeloid malignancies.
Jotte MRM; McNerney ME
Curr Opin Hematol; 2022 Mar; 29(2):92-102. PubMed ID: 35084368
[TBL] [Abstract][Full Text] [Related]
5. Distinct clinical and biological implications of
Aly M; Ramdzan ZM; Nagata Y; Balasubramanian SK; Hosono N; Makishima H; Visconte V; Kuzmanovic T; Adema V; Nazha A; Przychodzen BP; Kerr CM; Sekeres MA; Abazeed ME; Nepveu A; Maciejewski JP
Blood Adv; 2019 Jul; 3(14):2164-2178. PubMed ID: 31320321
[TBL] [Abstract][Full Text] [Related]
6. RAS transformation requires CUX1-dependent repair of oxidative DNA damage.
Ramdzan ZM; Vadnais C; Pal R; Vandal G; Cadieux C; Leduy L; Davoudi S; Hulea L; Yao L; Karnezis AN; Paquet M; Dankort D; Nepveu A
PLoS Biol; 2014 Mar; 12(3):e1001807. PubMed ID: 24618719
[TBL] [Abstract][Full Text] [Related]
7. CUX1 regulates human hematopoietic stem cell chromatin accessibility via the BAF complex.
Liu W; Kurkewich JL; Stoddart A; Khan S; Anandan D; Gaubil AN; Wolfgeher DJ; Jueng L; Kron SJ; McNerney ME
Cell Rep; 2024 May; 43(5):114227. PubMed ID: 38735044
[TBL] [Abstract][Full Text] [Related]
8. The function of CUX1 in oxidative DNA damage repair is needed to prevent premature senescence of mouse embryo fibroblasts.
Ramdzan ZM; Pal R; Kaur S; Leduy L; Bérubé G; Davoudi S; Vadnais C; Nepveu A
Oncotarget; 2015 Feb; 6(6):3613-26. PubMed ID: 25682875
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells.
An N; Khan S; Imgruet MK; Jueng L; Gurbuxani S; McNerney ME
Oncogene; 2023 Mar; 42(12):881-893. PubMed ID: 36725889
[TBL] [Abstract][Full Text] [Related]
10. Inactivating CUX1 mutations promote tumorigenesis.
Wong CC; Martincorena I; Rust AG; Rashid M; Alifrangis C; Alexandrov LB; Tiffen JC; Kober C; ; Green AR; Massie CE; Nangalia J; Lempidaki S; Döhner H; Döhner K; Bray SJ; McDermott U; Papaemmanuil E; Campbell PJ; Adams DJ
Nat Genet; 2014 Jan; 46(1):33-8. PubMed ID: 24316979
[TBL] [Abstract][Full Text] [Related]
11. CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage.
Vadnais C; Davoudi S; Afshin M; Harada R; Dudley R; Clermont PL; Drobetsky E; Nepveu A
Nucleic Acids Res; 2012 May; 40(10):4483-95. PubMed ID: 22319212
[TBL] [Abstract][Full Text] [Related]
12. The DNA repair function of CUX1 contributes to radioresistance.
Ramdzan ZM; Ginjala V; Pinder JB; Chung D; Donovan CM; Kaur S; Leduy L; Dellaire G; Ganesan S; Nepveu A
Oncotarget; 2017 Mar; 8(12):19021-19038. PubMed ID: 28147323
[TBL] [Abstract][Full Text] [Related]
13. CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers.
Ramdzan ZM; Nepveu A
Nat Rev Cancer; 2014 Oct; 14(10):673-82. PubMed ID: 25190083
[TBL] [Abstract][Full Text] [Related]
14. CUX1 transcription factor is a downstream effector of the proteinase-activated receptor 2 (PAR2).
Wilson BJ; Harada R; LeDuy L; Hollenberg MD; Nepveu A
J Biol Chem; 2009 Jan; 284(1):36-45. PubMed ID: 18952606
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor Cux1 in cerebellar granule cell development and medulloblastoma pathogenesis.
Topka S; Glassmann A; Weisheit G; Schüller U; Schilling K
Cerebellum; 2014 Dec; 13(6):698-712. PubMed ID: 25096634
[TBL] [Abstract][Full Text] [Related]
16. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
[TBL] [Abstract][Full Text] [Related]
17. Hyperphosphorylation by cyclin B/CDK1 in mitosis resets CUX1 DNA binding clock at each cell cycle.
Sansregret L; Gallo D; Santaguida M; Leduy L; Harada R; Nepveu A
J Biol Chem; 2010 Oct; 285(43):32834-32843. PubMed ID: 20729212
[TBL] [Abstract][Full Text] [Related]
18. CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms.
Krug S; Kühnemuth B; Griesmann H; Neesse A; Mühlberg L; Boch M; Kortenhaus J; Fendrich V; Wiese D; Sipos B; Friemel J; Gress TM; Michl P
Endocr Relat Cancer; 2014; 21(6):879-90. PubMed ID: 25248790
[TBL] [Abstract][Full Text] [Related]
19. Asynchronous expression of the homeodomain protein CUX1 in Sertoli cells and spermatids during spermatogenesis in mice.
Kroll MR; Viss ES; Lamb J; Horstman J; Powell A; Van Wyk A; Hinkkala K; Hoogland T; Schippers M; Shannon S; Carlton CG; Sharma M; Taylor A; Vanden Heuvel GB; Jelsma TN
Biol Reprod; 2011 Mar; 84(3):455-65. PubMed ID: 20980687
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7/del(7q).
McNerney ME; Brown CD; Peterson AL; Banerjee M; Larson RA; Anastasi J; Le Beau MM; White KP
Br J Haematol; 2014 Aug; 166(4):550-6. PubMed ID: 24931631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
